Therapeutic management of allergic diseases

Drug Metab Rev. 2009;41(3):301-43. doi: 10.1080/10837450902891204.

Abstract

Allergic diseases are characterized by the activation of inflammatory cells and by a massive release of mediators. The aim of this chapter was to describe succinctly the modes of action, indications, and side effects of the major antiallergic and antiasthmatic drugs. When considering the ideal pharmacokinetic characteristics of a drug, a poorly metabolized drug may confer a lower variability in plasma concentrations and metabolism-based drug interactions, although poorly metabolized drugs may be prone to transporter-based disposition and interactions. The ideal pharmacological properties of a drug include high binding affinity, high selectivity, and appropriate association and dissociation rates. Finally, from a patient perspective, the frequency and route of administration are important considerations for ease of use.

Publication types

  • Review

MeSH terms

  • Animals
  • Anti-Allergic Agents* / adverse effects
  • Anti-Allergic Agents* / pharmacokinetics
  • Anti-Allergic Agents* / pharmacology
  • Anti-Allergic Agents* / therapeutic use
  • Anti-Asthmatic Agents / adverse effects
  • Anti-Asthmatic Agents / pharmacokinetics
  • Anti-Asthmatic Agents / pharmacology
  • Anti-Asthmatic Agents / therapeutic use
  • Asthma / drug therapy
  • Asthma / immunology
  • Asthma / metabolism
  • Drug Design
  • Drug Interactions
  • Humans
  • Hypersensitivity / drug therapy*
  • Hypersensitivity / immunology
  • Hypersensitivity / metabolism
  • Mast Cells / drug effects
  • Mast Cells / immunology
  • Mast Cells / metabolism
  • Molecular Structure
  • Patient Satisfaction

Substances

  • Anti-Allergic Agents
  • Anti-Asthmatic Agents